Group One Trading, L.P. Cardiol Therapeutics Inc. Transaction History
Group One Trading, L.P.
- $3.01 Billion
- Q2 2024
A detailed history of Group One Trading, L.P. transactions in Cardiol Therapeutics Inc. stock. As of the latest transaction made, Group One Trading, L.P. holds 28,292 shares of CRDL stock, worth $56,301. This represents 0.0% of its overall portfolio holdings.
Number of Shares
28,292
Previous 3,667
671.53%
Holding current value
$56,301
Previous $6,000
850.0%
% of portfolio
0.0%
Previous 0.0%
Shares
4 transactions
Others Institutions Holding CRDL
# of Institutions
47Shares Held
5.51MCall Options Held
162KPut Options Held
7.4K-
Tejara Capital LTD London, X01.72MShares$3.43 Million1.26% of portfolio
-
Advisor Shares Investments LLC Bethesda, MD1.47MShares$2.92 Million0.55% of portfolio
-
Mmcap International Inc. Spc Grand Cayman, E9924KShares$1.84 Million0.36% of portfolio
-
Lion Street Advisors, LLC273KShares$543,8290.19% of portfolio
-
Foundations Investment Advisors, LLC162KShares$322,2800.01% of portfolio
About Cardiol Therapeutics Inc.
- Ticker CRDL
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 61,942,500
- Market Cap $123M
- Description
- Cardiol Therapeutics Inc., a clinical-stage life sciences company, focuses on the research and development of anti-fibrotic and anti-inflammatory therapies for the treatment of cardiovascular disease (CVD). Its lead product is CardiolRx, which is in Phase II/III multi-national, randomized, double-blind, and placebo-controlled study to evaluate t...